Uveitis Associated with Rifabutin Therapy
Edit Page
Report
Scan day: 06 February 2014 UTC
34
Virus safety - good
Description: Article outlining details of association between uveitis and Rifabutin therapy.
Uveitis Associated with Rifabutin Therapy Uveitis Associated with Rifabutin Therapy In 1993, the Public Health Service Task Force recommended use of Mycobutin * (rifabutin) at a daily dose of 300 mg for prophylaxis for disseminated Mycobacterium avium complex (MAC) infection in patients with human immunodeficiency virus (HIV) infection and less than 100 CD4+ T-lymphocytes/uL (1). However, uveitis (an inflammatory eye condition characterized by pain, redness, and possible temporary or permanent loss of vision) has been associated with rifabutin therapy.
Size: 558 chars
Contact Information
Email: —
Phone&Fax: —
Address: —
Extended: —
WEBSITE Info
| Page title: | Uveitis Associated with Rifabutin Therapy |
| Keywords: | |
| Description: | |
| IP-address: | 88.221.132.174 |
WHOIS Info
| NS | |
| WHOIS | Status: ACTIVE |
| Date |